BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 7, 2025
Home » Blogs » BioWorld Perspectives » Caught in Its Own Snare

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld / Oncology

Caught in Its Own Snare

July 16, 2012
By Mari Serebrov

A hunter walks into a bar and says, “Did you hear the one about the FDA?”

“You mean the time it shot itself in the foot?” the bartender responds.

“The left foot or the right foot?” another hunter asks, wiping the beer froth from his mouth.

“What difference does that make?” the first hunter asks.

“I want to know if it’s the one I’ve heard before. Or if this is a new one.”

The first rule of thumb for hunters is to know what they’re doing. Otherwise, they might shoot themselves in the foot – or worse. The second is to get a valid hunting license. The third is to make sure they don’t target animals that aren’t in season.

The FDA broke those rules when it set out to track down a few scientists who it claimed had gone rogue by sharing concerns about device approvals with members of Congress and the White House. The agency tried to get a license. “No way,” it was told by the Office of Inspector General. “That dog just won’t hunt.”

The FDA, being the FDA, decided it didn’t need a license. It loaded its guns, set its snares and hired a document-hunting outfitter to help it bag its trophies. The agency reportedly gave the guide a list of the targeted species and provided scents to sniff out along the document trail. Those smells led to the media and a few hound dog congressmen and their staffs – species that should be on every federal agency’s “do not hunt” list.

The hunters at the FDA justified their poaching by saying the scientists were fair game because they were leaking information, some of which could be proprietary. Those leaks could damage the agency, its mission and its reputation, they reasoned.

Intent on catching the big game and defending its unlicensed hunt, the FDA forgot to set the safety on its weapons. As a result, the outfitter tripped and misfired, publicly posting a database with the contents of all the document tracking, including the proprietary stuff and the scents used to mark the trail. The shot hit the FDA square in the mouth and left a gaping, oozing wound in its reputation.

Now, the FDA’s the prey. And these days, it’s looking a lot like a limping deer caught in the intensely hot headlights of Congress and the media.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 5, 2025.
  • Male hair loss

    Cosmo data positive for first new hair-loss approach in decades

    BioWorld
    Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing